News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
205,704 Results
Type
Article (15114)
Company Profile (24)
Press Release (190563)
Multimedia
Podcasts (53)
Webinars (4)
Section
Business (57284)
Career Advice (503)
Deals (6779)
Drug Delivery (75)
Drug Development (23516)
Employer Resources (41)
FDA (5043)
Job Trends (5269)
News (90025)
Policy (11424)
Tag
2025 Best Places to Work (4)
2026 Best Places to Work (5)
2027 BioCapital Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
40 Under 40 (1)
Academia (1719)
Academic (1)
Accelerated approval (45)
ADA (25)
Adcomms (11)
Allergies (71)
Alliances (15219)
ALS (100)
Alzheimer's disease (867)
Antibody-drug conjugate (ADC) (250)
Approvals (5535)
Artificial intelligence (359)
ASCO (109)
Autoimmune disease (206)
Automation (28)
Bankruptcy (68)
Belgium (16)
Best Places to Work (4714)
BIO (24)
Biologics (49)
BIOSECURE Act (16)
Biosimilars (93)
BioSpace Insights (61)
Biotechnology (17)
Bispecific (22)
Bladder cancer (105)
Brain cancer (49)
Breast cancer (354)
Cancer (3010)
Cardiovascular disease (264)
Career advice (447)
Career pathing (13)
CAR-T (108)
CDC (40)
CDMO (66)
Celiac Disease (1)
Cell-line development (1)
Cell therapy (331)
Cervical cancer (37)
Clinical research (21519)
Collaboration (1003)
Commercialization (40)
Company closure (1)
Compensation (136)
Complete response letters (25)
COVID-19 (1312)
CRISPR (60)
CRO (4)
C-suite (724)
Cystic fibrosis (97)
Data (4125)
Decentralized trials (2)
Denatured (16)
Depression (81)
Dermatology (98)
Diabetes (326)
Diagnostics (2520)
Digital health (37)
Diversity (4)
Diversity, equity & inclusion (15)
Drug discovery (157)
Drug pricing (134)
Drug shortages (10)
Duchenne muscular dystrophy (97)
Earnings (15915)
Editorial (30)
Employer branding (6)
Employer resources (36)
ESMO (135)
Events (26237)
Executive appointments (516)
Eye disease (5)
FDA (7028)
Fibrodysplasia Ossificans Progressiva (7)
Fragile X (5)
Friedreich's ataxia (10)
Frontotemporal dementia (10)
Funding (1094)
Gene editing (101)
Generative AI (30)
Gene therapy (272)
GLP-1 (366)
Government (3026)
Grass and pollen (2)
Guidances (164)
Healthcare (8186)
Hematology (92)
HIV (75)
Huntington's disease (13)
Idiopathic pulmonary fibrosis (6)
IgA nephropathy (143)
Immunology and inflammation (65)
Immuno-oncology (58)
Indications (146)
Infectious disease (1481)
Inflammatory bowel disease (82)
Inflation Reduction Act (5)
Influenza (48)
Intellectual property (150)
Interviews (79)
IPO (3125)
IRA (19)
Job creations (676)
Job search strategy (381)
JPM (22)
Kidney cancer (31)
Kidney disease (184)
Labor market (41)
Layoffs (102)
Leadership (11)
Legal (2028)
Licensing (48)
Liver cancer (30)
Longevity (28)
Lung cancer (395)
Lung diease (14)
Lymphoma (225)
Machine learning (31)
Management (13)
Manufacturing (527)
Marketing (19)
MASH (70)
Medical affairs (3)
Medical device (3317)
Medtech (3411)
Melanoma (61)
Mergers & acquisitions (4082)
Metabolic disorders (662)
Middle East (1)
mRNA (100)
Multiple sclerosis (77)
Multispecific (2)
NASH (3)
Netherlands (11)
Neurodegenerative disease (227)
Neuropsychiatric disorders (31)
Neuroscience (1635)
Neurotech (1)
NextGen: Class of 2026 (2979)
Non-profit (4012)
Now hiring (20)
Obesity (258)
Opinion (127)
Ovarian cancer (97)
Pain (121)
Pancreatic cancer (145)
Parkinson's disease (231)
Partnered (11)
Patents (273)
Patient advocacy (7)
Patient recruitment (334)
Patient selection (40)
Peanut (18)
People (20496)
Peptides (17)
Pharmaceutical (8)
Pharmacy benefit managers (22)
Phase 1 (5904)
Phase 2 (9233)
Phase 3 (7961)
Pipeline (5630)
Policy (199)
Postmarket research (852)
Preclinical (2457)
Press Release (19)
Prostate cancer (168)
Psychedelics (35)
Radiopharmaceuticals (143)
Rare diseases (637)
Real estate (1537)
Recruiting (17)
Regenerative medicine (11)
Regulatory (9426)
Reports (18)
Research institute (1589)
Resumes & cover letters (67)
Rett syndrome (15)
RNA editing (6)
RSV (37)
Saudi Arabia (1)
Schizophrenia (77)
Series A (143)
Series B (94)
Series C (1)
Sickle cell disease (72)
Special edition (5)
Spinal muscular atrophy (109)
Sponsored (19)
Startups (1070)
State (1)
Stem cells (3)
Stomach cancer (3)
Substance use disorders (11)
Supply chain (60)
Switzerland (7)
Tariffs (62)
Tax incentives (1)
The Weekly (36)
Vaccines (483)
Venture capital (59)
Weight loss (159)
Wet AMD (1)
Women's health (91)
Worklife (4)
Date
Last 7 days (256)
Last 30 days (1190)
Last 365 days (10730)
2026 (9940)
2025 (8971)
2024 (9779)
2023 (11424)
2022 (14866)
2021 (16705)
2020 (17837)
2019 (18206)
2018 (13431)
2017 (8466)
2016 (8814)
2015 (9772)
2014 (7337)
2013 (5800)
2012 (6185)
2011 (6636)
2010 (5264)
Location
Africa (309)
Alabama (19)
Alaska (3)
Arizona (160)
Arkansas (8)
Asia (12744)
Australia (2043)
California (4700)
Canada (1472)
China (1065)
Colorado (226)
Connecticut (285)
Delaware (208)
Europe (22745)
Florida (763)
Georgia (199)
Hawaii (1)
Idaho (19)
Illinois (448)
India (50)
Indiana (281)
Iowa (12)
Japan (341)
Kansas (44)
Kentucky (32)
Louisiana (37)
Maine (9)
Maryland (768)
Massachusetts (3091)
Michigan (114)
Minnesota (191)
Mississippi (3)
Missouri (105)
Montana (15)
Nebraska (10)
Nevada (113)
New Hampshire (30)
New Jersey (1633)
New Mexico (16)
New York (1488)
North Carolina (560)
North Dakota (4)
Northern California (2527)
Ohio (178)
Oklahoma (11)
Oregon (14)
Pennsylvania (875)
Puerto Rico (9)
Rhode Island (14)
South America (329)
South Carolina (27)
South Dakota (2)
Southern California (1865)
Tennessee (129)
Texas (818)
United States (17681)
Utah (157)
Vermont (1)
Virginia (139)
Washington D.C. (26)
Washington State (423)
West Virginia (2)
Wisconsin (73)
Wyoming (2)
205,704 Results for "national kidney foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
National Kidney Foundation Summit Advances Genetic Testing in Everyday Kidney Care
September 30, 2026
·
6 min read
Press Releases
National Kidney Foundation Workshop Identifies Major Gaps in Gout Treatment and Chronic Kidney Disease Care
June 26, 2026
·
6 min read
Press Releases
Dr. Marc Hurlbert Begins Tenure as Chief Executive Officer of the National Kidney Foundation
July 1, 2026
·
4 min read
Press Releases
National Kidney Foundation Innovation Fund Invests in Biohope to Advance Personalized Medicine in Kidney Transplantation
May 14, 2026
·
4 min read
Press Releases
Arthritis Foundation Unveils Transformed National Headquarters in Atlanta
October 22, 2026
·
4 min read
Press Releases
National Kidney Foundation Marks 75 Years of Transforming Kidney Health
December 2, 2025
·
3 min read
Venture capital
Estuary sails into kidney disease space with $103M for gene therapies
Estuary Biotherapeutics is seeking to address the root cause of autosomal dominant polycystic kidney disease with two gene therapy programs based on science from Yale.
October 16, 2026
·
1 min read
·
Annalee Armstrong
Insights
Why investors are taking another look at kidney disease
In this episode of Denatured, you’ll hear from Bruce Culleton, CEO at ProKidney and Demetri Maxim, CEO at Nephrogen. We discuss why kidney disease has long been a hard target for cell and gene therapies, and what new delivery strategies, therapeutic approaches and regulatory clarity mean for commercially viable products.
October 22, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Press Releases
Travere to Present New Data Supporting FILSPARI® (sparsentan) as Foundational Treatment in IgA Nephropathy and FSGS at ASN Kidney Week 2026
October 4, 2026
·
19 min read
Clinical research
Vertex opens up larger kidney disease opportunity with mid-stage readout
While Vertex is laser-focused on an upcoming FDA decision for povetacicept in immunoglobulin A nephropathy, the APOL1 inhibitor inaxaplin has demonstrated potential “best-in-class” data in a different kidney disease.
September 22, 2026
·
3 min read
·
Annalee Armstrong
1 of 20,571
Next